Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 409

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Stress granules, P-bodies and cancer

Open access
Anderson, Paul, Kedersha, Nancy, Ivanov, Pavel·2015·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms

Abstract

Cancer cells are exposed to adverse conditions in the tumor microenvironment, and utilize post-transcriptional control mechanisms to re-program gene expression in ways that enhance cell survival. Stress granules and processing bodies are RNA-containing granules that contribute to this process by modulating cellular signaling pathways, metabolic machinery, and stress response programs. This review examines evidence implicating RNA granules in the pathogenesis of cancer and discusses their potential as targets for anticancer therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbagrm.2014.11.009

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 153

  1. Fasken, 2005, Process or perish: quality control in mRNA biogenesis, Nat. Struct. Mol. Biol., 12, 482, 10.1038/nsmb945 · DOI
  2. Vogel, 2010, Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line, Mol. Syst. Biol., 6, 400, 10.1038/msb.2010.59 · DOI · Paper page
  3. Gebauer, 2012, From cis-regulatory elements to complex RNPs and back, Cold Spring Harb. Perspect. Biol., 4, a012245, 10.1101/cshperspect.a012245 · DOI
  4. Ivanov, 2013, Post-transcriptional regulatory networks in immunity, Immunol. Rev., 253, 253, 10.1111/imr.12051 · DOI
  5. Mitchell, 2014, Principles and properties of eukaryotic mRNPs, Mol. Cell, 54, 547, 10.1016/j.molcel.2014.04.033 · DOI · Paper page
  6. Bloch, 2013, GW/P-bodies and autoimmune disease, Adv. Exp. Med. Biol., 768, 61, 10.1007/978-1-4614-5107-5_5 · DOI
  7. Buchan, 2014, mRNP granules: assembly, function, and connections with disease, RNA Biol., 11, 10.4161/15476286.2014.972208 · DOI · Paper page
  8. Lloyd, 2013, Regulation of stress granules and P-bodies during RNA virus infection, Wiley interdiscip. Rev. RNA, 4, 317, 10.1002/wrna.1162 · DOI
  9. Vanderweyde, 2013, Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review, Gerontology, 59, 524, 10.1159/000354170 · DOI · Paper page
  10. Yamashita, 2005, Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover, Nat. Struct. Mol. Biol., 12, 1054, 10.1038/nsmb1016 · DOI · Paper page
  11. Chen, 2011, Mechanisms of deadenylation-dependent decay, Wiley Interdiscip. Rev. RNA, 2, 167, 10.1002/wrna.40 · DOI · Paper page
  12. Wahle, 2013, RNA decay machines: deadenylation by the Ccr4-not and Pan2-Pan3 complexes, Biochim. Biophys. Acta, 1829, 561, 10.1016/j.bbagrm.2013.01.003 · DOI · Paper page
  13. Ling, 2011, Structural and functional insights into eukaryotic mRNA decapping, Wiley Interdiscip. Rev. RNA, 2, 193, 10.1002/wrna.44 · DOI
  14. Anderson, 2009, RNA granules: post-transcriptional and epigenetic modulators of gene expression, Nat. Rev. Mol. Cell Biol., 10, 430, 10.1038/nrm2694 · DOI · Paper page
  15. Bashkirov, 1997, A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates, J. Cell Biol., 136, 761, 10.1083/jcb.136.4.761 · DOI · Paper page
  16. Ingelfinger, 2002, The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci, RNA, 8, 1489, 10.1017/S1355838202021726 · DOI · Paper page
  17. van Dijk, 2002, Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures, EMBO J., 21, 6915, 10.1093/emboj/cdf678 · DOI · Paper page
  18. Fenger-Gron, 2005, Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping, Mol. Cell, 20, 905, 10.1016/j.molcel.2005.10.031 · DOI · Paper page
  19. Yu, 2005, Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body, RNA, 11, 1795, 10.1261/rna.2142405 · DOI · Paper page
  20. Scheller, 2007, Identification of PatL1, a human homolog to yeast P body component Pat1, Biochim. Biophys. Acta, 1773, 1786, 10.1016/j.bbamcr.2007.08.009 · DOI
  21. Kedersha, 2005, Stress granules and processing bodies are dynamically linked sites of mRNP remodeling, J. Cell Biol., 169, 871, 10.1083/jcb.200502088 · DOI · Paper page
  22. Stoecklin, 2006, ARE-mRNA degradation requires the 5'-3' decay pathway, EMBO Rep., 7, 72, 10.1038/sj.embor.7400572 · DOI · Paper page
  23. Wilczynska, 2005, The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules, J. Cell Sci., 118, 981, 10.1242/jcs.01692 · DOI · Paper page
  24. Cougot, 2004, Cytoplasmic foci are sites of mRNA decay in human cells, J. Cell Biol., 165, 31, 10.1083/jcb.200309008 · DOI · Paper page
  25. Zheng, 2008, Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells, J. Cell Biol., 182, 89, 10.1083/jcb.200801196 · DOI · Paper page
  26. Ezzeddine, 2007, Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation, Mol. Cell. Biol., 27, 7791, 10.1128/MCB.01254-07 · DOI · Paper page
  27. Durand, 2007, Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies, J. Cell Biol., 178, 1145, 10.1083/jcb.200611086 · DOI · Paper page
  28. Sheth, 2006, Targeting of aberrant mRNAs to cytoplasmic processing bodies, Cell, 125, 1095, 10.1016/j.cell.2006.04.037 · DOI · Paper page
  29. Unterholzner, 2004, SMG7 acts as a molecular link between mRNA surveillance and mRNA decay, Mol. Cell, 16, 587, 10.1016/j.molcel.2004.10.013 · DOI · Paper page
  30. Franks, 2007, TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements, Genes Dev., 21, 719, 10.1101/gad.1494707 · DOI · Paper page
  31. Stoecklin, 2007, In a tight spot: ARE-mRNAs at processing bodies, Genes Dev., 21, 627, 10.1101/gad.1538807 · DOI
  32. Eystathioy, 2003, The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies, RNA, 9, 1171, 10.1261/rna.5810203 · DOI · Paper page
  33. Liu, 2005, MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies, Nat. Cell Biol., 7, 719, 10.1038/ncb1274 · DOI · Paper page
  34. Sen, 2005, Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies, Nat. Cell Biol., 7, 633, 10.1038/ncb1265 · DOI · Paper page
  35. Andrei, 2005, A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies, RNA, 11, 717, 10.1261/rna.2340405 · DOI · Paper page
  36. Ferraiuolo, 2005, A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay, J. Cell Biol., 170, 913, 10.1083/jcb.200504039 · DOI · Paper page
  37. Fujimura, 2008, Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies, RNA, 14, 425, 10.1261/rna.780708 · DOI
  38. Aizer, 2008, The dynamics of mammalian P body transport, assembly, and disassembly in vivo, Mol. Biol. Cell, 19, 4154, 10.1091/mbc.E08-05-0513 · DOI · Paper page
  39. Leung, 2006, Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules, Proc. Natl. Acad. Sci. U. S. A., 103, 18125, 10.1073/pnas.0608845103 · DOI · Paper page
  40. Hu, 2010, Nonsense-mediated mRNA decapping occurs on polyribosomes in Saccharomyces cerevisiae, Nat. Struct. Mol. Biol., 17, 244, 10.1038/nsmb.1734 · DOI
  41. Hu, 2009, Co-translational mRNA decay in Saccharomyces cerevisiae, Nature, 461, 225, 10.1038/nature08265 · DOI · Paper page
  42. Aizer, 2014, Quantifying mRNA targeting to P-bodies in living human cells reveals their dual role in mRNA decay and storage, J. Cell Sci., 127, 4443, 10.1242/jcs.152975 · DOI
  43. Anderson, 2009, Stress granules, Curr. Biol., 19, R397, 10.1016/j.cub.2009.03.013 · DOI · Paper page
  44. Ivanov, 2011, Stress puts TIA on TOP, Genes Dev., 25, 2119, 10.1101/gad.17838411 · DOI
  45. Kedersha, 2013, Stress granules and cell signaling: more than just a passing phase?, Trends Biochem. Sci., 38, 494, 10.1016/j.tibs.2013.07.004 · DOI · Paper page
  46. Kedersha, 1999, RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules, J. Cell Biol., 147, 1431, 10.1083/jcb.147.7.1431 · DOI · Paper page
  47. Holcik, 2005, Translational control in stress and apoptosis, Nat. Rev. Mol. Cell Biol., 6, 318, 10.1038/nrm1618 · DOI · Paper page
  48. Jackson, 2010, The mechanism of eukaryotic translation initiation and principles of its regulation, Nat. Rev. Mol. Cell Biol., 11, 113, 10.1038/nrm2838 · DOI · Paper page
  49. Pestova, 2001, Molecular mechanisms of translation initiation in eukaryotes, Proc. Natl. Acad. Sci. U. S. A., 98, 7029, 10.1073/pnas.111145798 · DOI · Paper page
  50. Kedersha, 2002, Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules, Mol. Biol. Cell, 13, 195, 10.1091/mbc.01-05-0221 · DOI · Paper page
  51. Kedersha, 2000, Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules, J. Cell Biol., 151, 1257, 10.1083/jcb.151.6.1257 · DOI · Paper page
  52. Tourriere, 2003, The RasGAP-associated endoribonuclease G3BP assembles stress granules, J. Cell Biol., 160, 823, 10.1083/jcb.200212128 · DOI · Paper page
  53. Gilks, 2004, Stress granule assembly is mediated by prion-like aggregation of TIA-1, Mol. Biol. Cell, 15, 5383, 10.1091/mbc.E04-08-0715 · DOI · Paper page
  54. Mollet, 2008, Translationally repressed mRNA transiently cycles through stress granules during stress, Mol. Biol. Cell, 19, 4469, 10.1091/mbc.E08-05-0499 · DOI · Paper page
  55. Bhattacharyya, 2006, Relief of microRNA-mediated translational repression in human cells subjected to stress, Cell, 125, 1111, 10.1016/j.cell.2006.04.031 · DOI · Paper page
  56. Gallois-Montbrun, 2007, Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules, J. Virol., 81, 2165, 10.1128/JVI.02287-06 · DOI · Paper page
  57. Pare, 2009, Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies, Mol. Biol. Cell, 20, 3273, 10.1091/mbc.E09-01-0082 · DOI
  58. Gallouzi, 2000, HuR binding to cytoplasmic mRNA is perturbed by heat shock, Proc. Natl. Acad. Sci. U. S. A., 97, 3073, 10.1073/pnas.97.7.3073 · DOI · Paper page
  59. Yang, 2007, Probing the mRNA processing body using protein macroarrays and "autoantigenomics", RNA, 13, 704, 10.1261/rna.411907 · DOI
  60. Stoecklin, 2004, MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay, EMBO J., 23, 1313, 10.1038/sj.emboj.7600163 · DOI · Paper page
  61. Ohn, 2008, A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly, Nat. Cell Biol., 10, 1224, 10.1038/ncb1783 · DOI · Paper page
  62. Serman, 2007, GW body disassembly triggered by siRNAs independently of their silencing activity, Nucleic Acids Res., 35, 4715, 10.1093/nar/gkm491 · DOI
  63. Decker, 2012, P-bodies and stress granules: possible roles in the control of translation and mRNA degradation, Cold Spring Harb. Perspect. Biol., 4, a012286, 10.1101/cshperspect.a012286 · DOI · Paper page
  64. Kulkarni, 2010, On track with P-bodies, Biochem. Soc. Trans., 38, 242, 10.1042/BST0380242 · DOI · Paper page
  65. Stoecklin, 2013, Relationship of GW/P-bodies with stress granules, Adv. Exp. Med. Biol., 768, 197, 10.1007/978-1-4614-5107-5_12 · DOI
  66. Anderson, 2008, Stress granules: the Tao of RNA triage, Trends Biochem. Sci., 33, 141, 10.1016/j.tibs.2007.12.003 · DOI · Paper page
  67. Baird, 2012, Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism, Adv. Nutr., 3, 307, 10.3945/an.112.002113 · DOI · Paper page
  68. Donnelly, 2013, The eIF2alpha kinases: their structures and functions, Cell. Mol. Life Sci., 70, 3493, 10.1007/s00018-012-1252-6 · DOI · Paper page
  69. Wek, 1995, The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids, Mol. Cell. Biol., 15, 4497, 10.1128/MCB.15.8.4497 · DOI · Paper page
  70. McEwen, 2005, Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure, J. Biol. Chem., 280, 16925, 10.1074/jbc.M412882200 · DOI · Paper page
  71. Harding, 2000, Regulated translation initiation controls stress-induced gene expression in mammalian cells, Mol. Cell, 6, 1099, 10.1016/S1097-2765(00)00108-8 · DOI · Paper page
  72. Ackerman, 2014, Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment, Trends Cell Biol., 24, 472, 10.1016/j.tcb.2014.06.001 · DOI · Paper page
  73. Clarke, 2014, Endoplasmic reticulum stress in malignancy, Cancer Cell, 25, 563, 10.1016/j.ccr.2014.03.015 · DOI · Paper page
  74. Porporato, 2011, Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review, Front. Pharmacol., 2, 49, 10.3389/fphar.2011.00049 · DOI · Paper page
  75. Costa, 2014, The role of reactive oxygen species and metabolism on cancer cells and their microenvironment, Semin. Cancer Biol., 25, 23, 10.1016/j.semcancer.2013.12.007 · DOI · Paper page
  76. Wall, 2012, Oxidative modification of proteins: an emerging mechanism of cell signaling, Front. Physiol., 3, 369, 10.3389/fphys.2012.00369 · DOI
  77. Shen, 2013, Arsenic binding to proteins, Chem. Rev., 113, 7769, 10.1021/cr300015c · DOI · Paper page
  78. Kwon, 2007, The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response, Genes Dev., 21, 3381, 10.1101/gad.461107 · DOI · Paper page
  79. Arimoto, 2008, Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways, Nat. Cell Biol., 10, 1324, 10.1038/ncb1791 · DOI · Paper page
  80. Kim, 2005, Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions, Mol. Cell. Biol., 25, 2450, 10.1128/MCB.25.6.2450-2462.2005 · DOI · Paper page
  81. Moeller, 2004, Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules, Cancer Cell, 5, 429, 10.1016/S1535-6108(04)00115-1 · DOI · Paper page
  82. Emara, 2012, Hydrogen peroxide induces stress granule formation independent of eIF2alpha phosphorylation, Biochem. Biophys. Res. Commun., 423, 763, 10.1016/j.bbrc.2012.06.033 · DOI
  83. Fujimura, 2012, Selenite targets eIF4E-binding protein-1 to inhibit translation initiation and induce the assembly of non-canonical stress granules, Nucleic Acids Res., 40, 8099, 10.1093/nar/gks566 · DOI
  84. Takahashi, 2013, Stress granules inhibit apoptosis by reducing reactive oxygen species production, Mol. Cell. Biol., 33, 815, 10.1128/MCB.00763-12 · DOI · Paper page
  85. Cande, 2004, Regulation of cytoplasmic stress granules by apoptosis-inducing factor, J. Cell Sci., 117, 4461, 10.1242/jcs.01356 · DOI
  86. Ortega, 2010, Human G3BP1 interacts with beta-F1-ATPase mRNA and inhibits its translation, J. Cell Sci., 123, 2685, 10.1242/jcs.065920 · DOI
  87. Liu, 2011, Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13, Cell, 147, 223, 10.1016/j.cell.2011.08.037 · DOI · Paper page
  88. Zhang, 2010, G3BP: a promising target for cancer therapy, Yao Xue Xue Bao, 45, 945
  89. Lin, 2013, USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation, Cell Rep., 5, 1639, 10.1016/j.celrep.2013.11.029 · DOI · Paper page
  90. Fournier, 2010, The chemotherapeutic agent bortezomib induces the formation of stress granules, Cancer Cell Int., 10, 12, 10.1186/1475-2867-10-12 · DOI
  91. Mazroui, 2007, Inhibition of the ubiquitin-proteasome system induces stress granule formation, Mol. Biol. Cell, 18, 2603, 10.1091/mbc.E06-12-1079 · DOI · Paper page
  92. Mazroui, 2006, Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation, Mol. Biol. Cell, 17, 4212, 10.1091/mbc.E06-04-0318 · DOI · Paper page
  93. Gareau, 2011, p21(WAF1/CIP1) upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis, PLoS One, 6, e20254, 10.1371/journal.pone.0020254 · DOI
  94. Kaehler, 2014, 5-Fluorouracil affects assembly of stress granules based on RNA incorporation, Nucleic Acids Res., 42, 6436, 10.1093/nar/gku264 · DOI
  95. Garcia, 2011, The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells, PLoS One, 6, e23887, 10.1371/journal.pone.0023887 · DOI
  96. Saito, 2011, MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6, Nucleic Acids Res., 39, 6086, 10.1093/nar/gkr194 · DOI
  97. Kim, 2007, Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A, EMBO J., 26, 5020, 10.1038/sj.emboj.7601920 · DOI
  98. Shin, 2009, 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity, Clin. Cancer Res., 15, 5414, 10.1158/1078-0432.CCR-08-3101 · DOI
  99. Bordeleau, 2005, Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation, Proc. Natl. Acad. Sci. U. S. A., 102, 10460, 10.1073/pnas.0504249102 · DOI · Paper page
  100. Low, 2005, Inhibition of eukaryotic translation initiation by the marine natural product pateamine A, Mol. Cell, 20, 709, 10.1016/j.molcel.2005.10.008 · DOI · Paper page
  101. Bordeleau, 2006, Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A, Nat. Chem. Biol., 2, 213, 10.1038/nchembio776 · DOI · Paper page
  102. Bordeleau, 2008, Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model, J. Clin. Invest., 118, 2651
  103. Bordeleau, 2006, RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation, Chem. Biol., 13, 1287, 10.1016/j.chembiol.2006.10.005 · DOI · Paper page
  104. Dang, 2006, Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A, J. Biol. Chem., 281, 32870, 10.1074/jbc.M606149200 · DOI · Paper page
  105. Hood, 2001, Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine, Apoptosis, 6, 207, 10.1023/A:1011340827558 · DOI
  106. Kuznetsov, 2009, Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A, Mol. Cancer Ther., 8, 1250, 10.1158/1535-7163.MCT-08-1026 · DOI
  107. Chambers, 2013, Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II, Org. Lett., 15, 1406, 10.1021/ol400401d · DOI
  108. Kogure, 2013, Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer, PLoS One, 8, e76136, 10.1371/journal.pone.0076136 · DOI
  109. Sun, 2014, Single-molecule kinetics of the eukaryotic initiation factor 4AI upon RNA unwinding, Structure, 22, 941, 10.1016/j.str.2014.04.014 · DOI
  110. Cencic, 2013, Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A, Blood Cancer J., 3, e128, 10.1038/bcj.2013.25 · DOI
  111. Tsumuraya, 2011, Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia, Biochem. Pharmacol., 81, 713, 10.1016/j.bcp.2010.12.025 · DOI
  112. Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017 · DOI · Paper page
  113. Laplante, 2013, Regulation of mTORC1 and its impact on gene expression at a glance, J. Cell Sci., 126, 1713, 10.1242/jcs.125773 · DOI · Paper page
  114. Wippich, 2013, Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling, Cell, 152, 791, 10.1016/j.cell.2013.01.033 · DOI · Paper page
  115. Yoshida, 2011, Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway, J. Biol. Chem., 286, 32651, 10.1074/jbc.M111.238014 · DOI
  116. Thedieck, 2013, Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells, Cell, 154, 859, 10.1016/j.cell.2013.07.031 · DOI · Paper page
  117. Damgaard, 2011, Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR, Genes Dev., 25, 2057, 10.1101/gad.17355911 · DOI · Paper page
  118. Polunovsky, 2006, The cap-dependent translation apparatus integrates and amplifies cancer pathways, RNA Biol., 3, 10, 10.4161/rna.3.1.2718 · DOI
  119. Sonenberg, 2009, Regulation of translation initiation in eukaryotes: mechanisms and biological targets, Cell, 136, 731, 10.1016/j.cell.2009.01.042 · DOI · Paper page
  120. Wendel, 2004, Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy, Nature, 428, 332, 10.1038/nature02369 · DOI · Paper page
  121. Adams, 2011, RACK1, A multifaceted scaffolding protein: structure and function, Cell Commun. Signal., 9, 22, 10.1186/1478-811X-9-22 · DOI · Paper page
  122. Gandin, 2013, RACK1 function in cell motility and protein synthesis, Genes Cancer, 4, 369, 10.1177/1947601913486348 · doi:10.1177/1947601913486348
  123. Li, 2014, RACK1, a versatile hub in cancer, Oncogene
  124. Carrick, 2007, Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines, Arch. Biochem. Biophys., 462, 278, 10.1016/j.abb.2007.04.011 · DOI
  125. Brennan, 2009, The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis, Cancer Res., 69, 5168, 10.1158/0008-5472.CAN-08-4238 · DOI · Paper page
  126. Stoecklin, 2003, A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA, Oncogene, 22, 3554, 10.1038/sj.onc.1206418 · DOI
  127. Gebeshuber, 2009, miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis, EMBO Rep., 10, 400, 10.1038/embor.2009.9 · DOI · Paper page
  128. Rounbehler, 2012, Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state, Cell, 150, 563, 10.1016/j.cell.2012.06.033 · DOI
  129. Lopez de Silanes, 2003, Role of the RNA-binding protein HuR in colon carcinogenesis, Oncogene, 22, 7146, 10.1038/sj.onc.1206862 · DOI · Paper page
  130. Abdelmohsen, 2012, RNA-binding protein AUF1 represses Dicer expression, Nucleic Acids Res., 40, 11531, 10.1093/nar/gks930 · DOI
  131. Mihailovich, 2010, Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression, Bioessays, 32, 109, 10.1002/bies.200900122 · DOI · Paper page
  132. Balzer, 2007, Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules, RNA Biol., 4, 16, 10.4161/rna.4.1.4364 · DOI · Paper page
  133. Eliseeva, 2011, Y-box-binding protein 1 (YB-1) and its functions, Biochemistry, 76, 1402
  134. Zhou, 2013, LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells, Int. J. Biochem. Cell Biol., 45, 973, 10.1016/j.biocel.2013.02.006 · DOI · Paper page
  135. Shyh-Chang, 2013, Lin28: primal regulator of growth and metabolism in stem cells, Cell Stem Cell, 12, 395, 10.1016/j.stem.2013.03.005 · DOI · Paper page
  136. Viswanathan, 2009, Lin28 promotes transformation and is associated with advanced human malignancies, Nat. Genet., 41, 843, 10.1038/ng.392 · DOI · Paper page
  137. Evdokimova, 2009, Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition, Cancer Cell, 15, 402, 10.1016/j.ccr.2009.03.017 · DOI · Paper page
  138. Pizzo, 2013, Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival, J. Cell Sci., 126, 4308, 10.1242/jcs.134551 · DOI
  139. Li, 2012, Emerging role of angiogenin in stress response and cell survival under adverse conditions, J. Cell. Physiol., 227, 2822, 10.1002/jcp.23051 · DOI · Paper page
  140. Li, 2010, Angiogenin-mediated rRNA transcription in cancer and neurodegeneration, Int. J. Biochem. Mol. Biol., 1, 26
  141. Yamasaki, 2009, Angiogenin cleaves tRNA and promotes stress-induced translational repression, J. Cell Biol., 185, 35, 10.1083/jcb.200811106 · DOI · Paper page
  142. Ivanov, 2011, Angiogenin-induced tRNA fragments inhibit translation initiation, Mol. Cell, 43, 613, 10.1016/j.molcel.2011.06.022 · DOI · Paper page
  143. Fu, 2005, Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor, Cancer Gene Ther., 12, 268, 10.1038/sj.cgt.7700742 · DOI
  144. Pan, 2012, Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells, Int. J. Biochem. Cell Biol., 44, 998, 10.1016/j.biocel.2012.03.008 · doi:10.1016/j.biocel.2012.03.008
  145. Yao, 2013, A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells, Cell Tissue Res., 353, 409, 10.1007/s00441-013-1638-2 · doi:10.1007/s00441-013-1638-2
  146. Li, 2010, eIF5A promotes translation elongation, polysome disassembly and stress granule assembly, PLoS ONE, 5, e9942, 10.1371/journal.pone.0009942 · DOI
  147. Fujimura, 2014, A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer, Cancer Res., 74, 6671, 10.1158/0008-5472.CAN-14-1031 · DOI
  148. Hilliker, 2011, The DEAD-box protein Ded1 modulates translation by the formation and resolution of an eIF4F-mRNA complex, Mol. Cell, 43, 962, 10.1016/j.molcel.2011.08.008 · DOI · Paper page
  149. Shih, 2012, Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response, Biochem. J., 441, 119, 10.1042/BJ20110739 · DOI · Paper page
  150. Bol, 2013, Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer, PLoS One, 8, e63548, 10.1371/journal.pone.0063548 · DOI
  151. Chen, 2014, DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway, Oncogene
  152. Ghildiyal, 2009, Small silencing RNAs: an expanding universe, Nat. Rev. Genet., 10, 94, 10.1038/nrg2504 · DOI · Paper page
  153. Palanichamy, 2014, miRNA dysregulation in cancer: towards a mechanistic understanding, Front. Genet., 5, 54, 10.3389/fgene.2014.00054 · DOI

Cited by

See all 409

Metadata

Authors
Anderson, P., Kedersha, N., & Ivanov, P.
Venue
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Publisher
Elsevier BV
Published
2015-07
Volume
1849
Issue
7
Pages
861-870
ISSN
1874-9399 (ISSN-L)
OpenAlex
W2072281823
Cited by
409
References
19
FWCI
10.59
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institutes of Health (CA168872, GM111700)
  • Muscular Dystrophy Association (ID158521)
  • ALS Association (N7W220)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stress granules, P-bodies and cancer. https://app.cochat.ai/papers/10.1016/j.bbagrm.2014.11.009
The paper
Anderson, P., Kedersha, N., & Ivanov, P. (2015). Stress granules, P-bodies and cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. https://doi.org/10.1016/j.bbagrm.2014.11.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.